These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 34732273)

  • 1. Estimating the SARS-CoV2 infections detection rate and cumulative incidence in the World Health Organization African Region 10 months into the pandemic.
    Impouma B; Mboussou F; Shahpar C; Wolfe CM; Farham B; Williams GS; Karamagi H; Ngom R; Nsenga N; Flahault A; Codeço CT; Yoti Z; Kasolo F; Keiser O
    Epidemiol Infect; 2021 Nov; 149():e264. PubMed ID: 34732273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysing the reported incidence of COVID-19 and factors associated in the World Health Organization African region as of 31 December 2020.
    Mboussou F; Impouma B; Farham B; Wolfe CM; Williams GS; Ngom R; Nzingou M; Merzouki A; Orel E; Ahmed YA; Keiser O; Moeti MR
    Epidemiol Infect; 2021 Aug; 149():e256. PubMed ID: 34392872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The COVID-19 pandemic in the WHO African region: the first year (February 2020 to February 2021).
    Impouma B; Mboussou F; Farham B; Wolfe CM; Johnson K; Clary C; Mihigo R; Nsenga N; Talisuna A; Yoti Z; Flahault A; Keiser O; Gueye AS; Cabore J; Moeti M
    Epidemiol Infect; 2021 Nov; 149():e263. PubMed ID: 34732270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 in WHO African Region: Account and Correlation of Epidemiological Indices with Some Selected Health-related Metrics.
    Okoroiwu HU; Ogar CO; Abunimye DA; Okafor IM; Uchendu IK
    Ethiop J Health Sci; 2021 Nov; 31(6):1075-1088. PubMed ID: 35392328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A SARS-CoV-2 Surveillance System in Sub-Saharan Africa: Modeling Study for Persistence and Transmission to Inform Policy.
    Post LA; Argaw ST; Jones C; Moss CB; Resnick D; Singh LN; Murphy RL; Achenbach CJ; White J; Issa TZ; Boctor MJ; Oehmke JF
    J Med Internet Res; 2020 Nov; 22(11):e24248. PubMed ID: 33211026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential effects of widespread community transmission of SARS-CoV-2 infection in the World Health Organization African Region: a predictive model.
    Cabore JW; Karamagi HC; Kipruto H; Asamani JA; Droti B; Seydi ABW; Titi-Ofei R; Impouma B; Yao M; Yoti Z; Zawaira F; Tumusiime P; Talisuna A; Kasolo FC; Moeti MR
    BMJ Glob Health; 2020 May; 5(5):. PubMed ID: 32451366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia.
    Meo SA; Fahad Al-Jassir F; Al-Qahtani S; Albarrak R; Usmani AM; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):7185-7191. PubMed ID: 34859883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The first and second waves of the COVID-19 pandemic in Africa: a cross-sectional study.
    Salyer SJ; Maeda J; Sembuche S; Kebede Y; Tshangela A; Moussif M; Ihekweazu C; Mayet N; Abate E; Ouma AO; Nkengasong J
    Lancet; 2021 Apr; 397(10281):1265-1275. PubMed ID: 33773118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 in the MENA Region: Facts and Findings.
    Younis NK; Rahm M; Bitar F; Arabi M
    J Infect Dev Ctries; 2021 Mar; 15(3):342-349. PubMed ID: 33839707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 Surveillance in the Middle East and North Africa: Longitudinal Trend Analysis.
    Post L; Marogi E; Moss CB; Murphy RL; Ison MG; Achenbach CJ; Resnick D; Singh L; White J; Boctor MJ; Welch SB; Oehmke JF
    J Med Internet Res; 2021 Jan; 23(1):e25830. PubMed ID: 33302252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 in the 47 countries of the WHO African region: a modelling analysis of past trends and future patterns.
    Cabore JW; Karamagi HC; Kipruto HK; Mungatu JK; Asamani JA; Droti B; Titi-Ofei R; Seydi ABW; Kidane SN; Balde T; Gueye AS; Makubalo L; Moeti MR
    Lancet Glob Health; 2022 Aug; 10(8):e1099-e1114. PubMed ID: 35659911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The first laboratory-confirmed imported infections of SARS-CoV-2 in Sudan.
    Aljak ER; Eldigail M; Mahmoud I; Elhassan RM; Elduma A; Ibrahim AA; Ali Y; Weaver SC; Ahmed A
    Trans R Soc Trop Med Hyg; 2021 Jan; 115(1):103-109. PubMed ID: 33319246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 in the WHO African region: using risk assessment to inform decisions on public health and social measures.
    Impouma B; Mboussou F; Wolfe CM; Farham B; Williams GS; Ogundiran O; Ngom R; Nzingou M; Flahault A; Codeço CT; Talisuna A; Yoti Z; Keiser O
    Epidemiol Infect; 2021 May; 149():e259. PubMed ID: 33966683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of weather conditions on incidence and mortality of COVID-19 pandemic in Africa.
    Meo SA; Abukhalaf AA; Alomar AA; Aljudi TW; Bajri HM; Sami W; Akram J; Akram SJ; Hajjar W
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9753-9759. PubMed ID: 33015822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 infection in Africa: a systematic review and meta-analysis of standardised seroprevalence studies, from January 2020 to December 2021.
    Lewis HC; Ware H; Whelan M; Subissi L; Li Z; Ma X; Nardone A; Valenciano M; Cheng B; Noel K; Cao C; Yanes-Lane M; Herring BL; Talisuna A; Ngoy N; Balde T; Clifton D; Van Kerkhove MD; Buckeridge D; Bobrovitz N; Okeibunor J; Arora RK; Bergeri I;
    BMJ Glob Health; 2022 Aug; 7(8):. PubMed ID: 35998978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early trends for SARS-CoV-2 infection in central and north Texas and impact on other circulating respiratory viruses.
    Mutnal MB; Arroliga AC; Walker K; Mohammad A; Brigmon MM; Beaver RM; Midturi JK; Rao A
    J Med Virol; 2020 Oct; 92(10):2130-2138. PubMed ID: 32410236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimating the Proportion of Asymptomatic COVID-19 Cases in an Italian Region with Intermediate Incidence during the First Pandemic Wave: An Observational Retrospective Study.
    Martinelli D; Fortunato F; Mazzilli S; Bisceglia L; Lopalco PL; Prato R
    Biomed Res Int; 2022; 2022():3401566. PubMed ID: 35005026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global seroprevalence of SARS-CoV-2 antibodies: A systematic review and meta-analysis.
    Bobrovitz N; Arora RK; Cao C; Boucher E; Liu M; Donnici C; Yanes-Lane M; Whelan M; Perlman-Arrow S; Chen J; Rahim H; Ilincic N; Segal M; Duarte N; Van Wyk J; Yan T; Atmaja A; Rocco S; Joseph A; Penny L; Clifton DA; Williamson T; Yansouni CP; Evans TG; Chevrier J; Papenburg J; Cheng MP
    PLoS One; 2021; 16(6):e0252617. PubMed ID: 34161316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Emergence of SARS-CoV-2 Variant(s) and Its Impact on the Prevalence of COVID-19 Cases in the Nabatieh Region, Lebanon.
    Noureddine FY; Chakkour M; El Roz A; Reda J; Al Sahily R; Assi A; Joma M; Salami H; Hashem SJ; Harb B; Salami A; Ghssein G
    Med Sci (Basel); 2021 Jun; 9(2):. PubMed ID: 34199617
    [No Abstract]   [Full Text] [Related]  

  • 20. SARS-CoV-2 / COVID-19 in patients on the Swiss national transplant waiting list.
    Benden C; Haile S; Kruegel N; Beyeler F; Aubert JD; Binet I; Golshayan D; Hadaya K; Mueller T; Parvex P; Immer F
    Swiss Med Wkly; 2020 Dec; 150():w20451. PubMed ID: 33382903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.